Nilotinib Vs Nilotinib Plus Pegylated Interferon-alpha2b Induction and Nilotinib or Pegylated Interferon-alpha2b Maintenance Therapy for Newly Diagnosed BCR-ABL plus Chronic Myeloid Leukemia Patients in Chronic Phase: Interim Analysis of the Tiger (CML V)-Study - Hochhaus, Andreas; Saussele, Susanne; Baerlocher, Gabriela M.; Bruemmendorf, Tim H.; Burchert, Andreas; La Rosee, Paul; Hasford, Joerg; Hehlmann, Ruediger; Heim, Dominik; Krause, Stefan; Le Coutre, Philipp; Niederwieser, Dietger; et al. (BLOOD, 2018)
CRIS-Team WoS Importer:2019-03-06